Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.

Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.

Acute oral administration of selective serotonin re-uptake inhibitors (SSRIs) increases plasma cortisol by facilitating brain serotonin activity. Recently, salivary cortisol sampling has grown in popularity as a noninvasive means of assessing HPA axis activity. The aim of the present study was to fi...

書誌詳細
主要な著者:	Nadeem, H, Attenburrow, M, Cowen, P
フォーマット:	Journal article
言語:	English
出版事項:	2004

類似資料

Low-dose citalopram as a 5-HT neuroendocrine probe.
著者:: Attenburrow, M, 等
出版事項: (2001)

The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.
著者:: Glue, P, 等
出版事項: (1986)

Effect of oestradiol treatment on 5-HT and dopamine-mediated neuroendocrine responses.
著者:: Best, N, 等
出版事項: (1992)

The effects of a low tryptophan diet on brain 5 -HT metabolism and 5-HT-mediated neuroendocrine responses in the male rat.
著者:: Franklin, M, 等
出版事項: (1995)

A Síndrome do QT Longo Associada ao uso de Citalopram e Escitalopram / The Long QT Syndrome Associated to Citalopram and Escitalopram
著者:: Filipe Santos Falani, 等
出版事項: (2016-06-01)

Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression.
著者:: Cowen, P, 等
出版事項: (1989)

ABNORMAL 5-HT NEUROENDOCRINE FUNCTION IN DEPRESSION
著者:: Cowen, P
出版事項: (1990)

Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport
著者:: Harvey G. Roweth, 等
出版事項: (2018-02-01)

A Study about Escitalopram Versus Citalopram in the Treatment of Depressive Disorders
著者:: Jasim M. Shindi, 等
出版事項: (2015-08-01)

Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study.
著者:: Elena Qirjazi, 等
出版事項: (2016-01-01)

Prediction of Ventricular Arrhythmias by QRS/QTc - Ratio in Citalopram or Escitalopram Intoxication
著者:: Erik Sveberg Dietrichs, 等
出版事項: (2022-03-01)

Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
著者:: Sharpley, A, 等
出版事項: (1994)

5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
著者:: Park, S, 等
出版事項: (1996)

Neuroendocrine challenge tests: assessment of 5-HT function in anxiety and depression.
著者:: Power, A, 等
出版事項: (1992)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
著者:: Stacey L. Aldrich, 等
出版事項: (2019-02-01)

Chromium treatment decreases the sensitivity of 5-HT2A receptors.
著者:: Attenburrow, M, 等
出版事項: (2002)

Desipramine treatment in normal subjects. Effects on neuroendocrine responses to tryptophan and on platelet serotonin (5-HT)-related receptors.
著者:: Cowen, P, 等
出版事項: (1986)

Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
著者:: Gartside, SE, 等
出版事項: (1990)

The Effects of Citalopram, a 5-HT Re-Uptake Inhibitor, on Passive Avoidance Learning Task in Rat
著者:: Abdolrahman Sarihi, 等
出版事項: (1998-09-01)

Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol-lowering drugs.
著者:: Delva, N, 等
出版事項: (1996)

ENDOCRINOLOGIC RESPONSES TO 5-HT
著者:: Cowen, P, 等
出版事項: (1990)

Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants
著者:: Alkhafaji Ali A, 等
出版事項: (2012-11-01)

Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.
著者:: Walsh, A, 等
出版事項: (1991)

Double blind, randomised trial to compare efficacy of escitalopram versus citalopram for interferon induced depression in hepatitis C patients
著者:: Uzma Shakeel, 等
出版事項: (2020-09-01)

Effect of a single dose of citalopram on amygdala response to emotional faces.
著者:: Murphy, SE, 等
出版事項: (2009)

5-HT1A receptor sensitivity in major depression. A neuroendocrine study with buspirone.
著者:: Cowen, P, 等
出版事項: (1994)

Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study
著者:: Mahmood Mahajna, 等
出版事項: (2023-12-01)

Imaging the acute effects of citalopram on the amygdala in healthy volunteers
著者:: Murphy, SE, 等
出版事項: (2006)

Contrasting effects of citalopram and reboxetine on waking salivary cortisol.
著者:: Harmer, C, 等
出版事項: (2003)

The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function.
著者:: Attenburrow, M, 等
出版事項: (2003)

Citalopram Neuroendocrine Challenge Shows Altered Tryptophan and Kynurenine Metabolism in Migraine
著者:: Kinga Gecse, 等
出版事項: (2022-07-01)

Lithium increases 5-HT-mediated prolactin release.
著者:: McCance, S, 等
出版事項: (1989)

Prescribing Practice of Citalopram and Escitalopram in Older Adults Following the 2014 MHRA Guidance of Associated QTc Prolongation: A Clinical Audit
著者:: Shreyan Kar, 等
出版事項: (2024-06-01)

Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments.
著者:: Gartside, SE, 等
出版事項: (1992)

Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses.
著者:: Elphick, M, 等
出版事項: (1990)

Serious arrhythmia in initiators of citalopram, escitalopram, and other selective serotonin reuptake inhibitors: A population‐based cohort study in older adults
著者:: Mia Aakjær, 等
出版事項: (2022-09-01)

Short-term escitalopram treatment and hippocampal volume.
著者:: Godlewska, B, 等
出版事項: (2014)

Augmentation strategies: 5-HT and beyond
著者:: Cowen, P
出版事項: (2002)

Cortisol modulation of 5-HT-mediated growth hormone release in recovered depressives
著者:: Bhagwagar, Z, 等
出版事項: (2001)

THE EFFECT OF TRYPTOPHAN ON BRAIN 5-HT FUNCTION - A REVIEW
著者:: Cowen, P
出版事項: (1994)